Sharan Kimberly Rai, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Gout | 17 | 2021 | 573 | 2.510 |
Why?
|
Gout Suppressants | 6 | 2019 | 166 | 0.690 |
Why?
|
Diet, Mediterranean | 2 | 2023 | 700 | 0.680 |
Why?
|
Allopurinol | 5 | 2019 | 191 | 0.590 |
Why?
|
Cost of Illness | 2 | 2017 | 1860 | 0.550 |
Why?
|
Polymyositis | 1 | 2015 | 75 | 0.520 |
Why?
|
Dermatomyositis | 1 | 2015 | 224 | 0.440 |
Why?
|
Hyperuricemia | 3 | 2019 | 211 | 0.380 |
Why?
|
Hospital Costs | 1 | 2017 | 985 | 0.370 |
Why?
|
Lupus Erythematosus, Systemic | 4 | 2018 | 2104 | 0.360 |
Why?
|
Arthritis, Rheumatoid | 6 | 2018 | 3712 | 0.360 |
Why?
|
Cause of Death | 4 | 2017 | 3582 | 0.360 |
Why?
|
Diet, Carbohydrate-Restricted | 2 | 2023 | 262 | 0.340 |
Why?
|
Uric Acid | 5 | 2021 | 766 | 0.320 |
Why?
|
British Columbia | 3 | 2019 | 244 | 0.320 |
Why?
|
Disability Evaluation | 1 | 2015 | 1828 | 0.300 |
Why?
|
Atherosclerosis | 1 | 2023 | 3444 | 0.290 |
Why?
|
Drug Eruptions | 2 | 2019 | 297 | 0.270 |
Why?
|
Rheumatic Diseases | 3 | 2018 | 593 | 0.270 |
Why?
|
Hospitalization | 5 | 2019 | 10259 | 0.250 |
Why?
|
Hypertension | 4 | 2021 | 8479 | 0.240 |
Why?
|
Antirheumatic Agents | 4 | 2018 | 1338 | 0.220 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2018 | 3255 | 0.210 |
Why?
|
Severity of Illness Index | 3 | 2019 | 15535 | 0.200 |
Why?
|
Health Care Costs | 1 | 2015 | 3208 | 0.200 |
Why?
|
Uricosuric Agents | 2 | 2019 | 28 | 0.190 |
Why?
|
Probenecid | 2 | 2019 | 76 | 0.190 |
Why?
|
Diuretics | 2 | 2020 | 591 | 0.180 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2023 | 11726 | 0.170 |
Why?
|
Health Occupations | 1 | 2020 | 224 | 0.170 |
Why?
|
Obesity | 5 | 2023 | 12746 | 0.160 |
Why?
|
Diet, Fat-Restricted | 1 | 2020 | 320 | 0.150 |
Why?
|
Proportional Hazards Models | 6 | 2018 | 12356 | 0.150 |
Why?
|
Sulfinpyrazone | 1 | 2016 | 14 | 0.150 |
Why?
|
Population Growth | 1 | 2016 | 52 | 0.140 |
Why?
|
Spondylitis, Ankylosing | 1 | 2017 | 156 | 0.130 |
Why?
|
Poisson Distribution | 1 | 2017 | 513 | 0.130 |
Why?
|
Colchicine | 1 | 2016 | 244 | 0.130 |
Why?
|
Middle Aged | 23 | 2023 | 213390 | 0.130 |
Why?
|
Incidence | 6 | 2020 | 20952 | 0.120 |
Why?
|
Comorbidity | 4 | 2016 | 10388 | 0.120 |
Why?
|
Hydroxychloroquine | 1 | 2018 | 412 | 0.120 |
Why?
|
Myocardial Infarction | 1 | 2015 | 11718 | 0.120 |
Why?
|
Adiposity | 1 | 2023 | 1806 | 0.110 |
Why?
|
Medication Adherence | 2 | 2015 | 2063 | 0.110 |
Why?
|
Abnormalities, Drug-Induced | 1 | 2016 | 317 | 0.110 |
Why?
|
Primary Prevention | 1 | 2020 | 1167 | 0.110 |
Why?
|
Aged | 19 | 2020 | 163288 | 0.110 |
Why?
|
Diet Surveys | 1 | 2017 | 1173 | 0.110 |
Why?
|
Stroke | 1 | 2015 | 9981 | 0.110 |
Why?
|
Stevens-Johnson Syndrome | 1 | 2016 | 281 | 0.110 |
Why?
|
Alcohol Drinking | 3 | 2020 | 3966 | 0.110 |
Why?
|
Male | 24 | 2021 | 350115 | 0.100 |
Why?
|
Ophthalmology | 1 | 2018 | 508 | 0.100 |
Why?
|
Databases, Factual | 8 | 2018 | 7730 | 0.100 |
Why?
|
Hyperlipidemias | 1 | 2016 | 789 | 0.100 |
Why?
|
Cohort Studies | 10 | 2020 | 40559 | 0.100 |
Why?
|
Humans | 32 | 2023 | 744366 | 0.090 |
Why?
|
Follow-Up Studies | 7 | 2023 | 39052 | 0.090 |
Why?
|
Female | 23 | 2021 | 380193 | 0.090 |
Why?
|
Cardiovascular Diseases | 4 | 2020 | 15160 | 0.090 |
Why?
|
Myocardial Ischemia | 1 | 2019 | 2148 | 0.080 |
Why?
|
Multivariate Analysis | 3 | 2017 | 12244 | 0.080 |
Why?
|
Pilot Projects | 1 | 2021 | 8319 | 0.080 |
Why?
|
Risk | 2 | 2017 | 9688 | 0.080 |
Why?
|
Disease Management | 1 | 2018 | 2460 | 0.070 |
Why?
|
Glucocorticoids | 1 | 2016 | 2108 | 0.070 |
Why?
|
Linear Models | 1 | 2017 | 5953 | 0.070 |
Why?
|
Risk Factors | 7 | 2023 | 72296 | 0.070 |
Why?
|
Autoimmune Diseases | 1 | 2018 | 2134 | 0.070 |
Why?
|
Prevalence | 3 | 2019 | 15221 | 0.070 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 2282 | 0.070 |
Why?
|
Adult | 12 | 2023 | 214052 | 0.070 |
Why?
|
Survival Rate | 2 | 2017 | 12788 | 0.060 |
Why?
|
Cross-Sectional Studies | 2 | 2023 | 25039 | 0.060 |
Why?
|
Longitudinal Studies | 2 | 2018 | 13991 | 0.060 |
Why?
|
Health Personnel | 1 | 2017 | 3219 | 0.060 |
Why?
|
Nutrition Surveys | 2 | 2019 | 1660 | 0.050 |
Why?
|
Survival Analysis | 1 | 2015 | 10252 | 0.050 |
Why?
|
Cost-Benefit Analysis | 1 | 2015 | 5388 | 0.050 |
Why?
|
Pregnancy Complications | 1 | 2016 | 2861 | 0.050 |
Why?
|
Carbohydrates | 1 | 2023 | 394 | 0.050 |
Why?
|
Brain Ischemia | 1 | 2015 | 3265 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2018 | 7282 | 0.050 |
Why?
|
Body Mass Index | 4 | 2020 | 12721 | 0.050 |
Why?
|
Prospective Studies | 3 | 2023 | 53290 | 0.050 |
Why?
|
Depression | 1 | 2020 | 7759 | 0.050 |
Why?
|
Propensity Score | 2 | 2017 | 1781 | 0.040 |
Why?
|
Prognosis | 2 | 2018 | 29060 | 0.040 |
Why?
|
Drug Dosage Calculations | 1 | 2018 | 114 | 0.040 |
Why?
|
Israel | 1 | 2020 | 796 | 0.040 |
Why?
|
Diabetes Mellitus | 1 | 2016 | 5749 | 0.040 |
Why?
|
Risk Assessment | 2 | 2016 | 23336 | 0.040 |
Why?
|
Diet, Reducing | 1 | 2020 | 462 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2019 | 10943 | 0.030 |
Why?
|
Mortality | 2 | 2018 | 2864 | 0.030 |
Why?
|
Heart Failure | 1 | 2019 | 10895 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 2021 | 2029 | 0.030 |
Why?
|
Fruit | 1 | 2021 | 1142 | 0.030 |
Why?
|
Vegetables | 1 | 2021 | 1182 | 0.030 |
Why?
|
Alzheimer Disease | 1 | 2015 | 8038 | 0.030 |
Why?
|
Eating | 1 | 2021 | 1536 | 0.030 |
Why?
|
Weight Gain | 1 | 2023 | 2293 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2017 | 63107 | 0.030 |
Why?
|
United States | 5 | 2019 | 69872 | 0.030 |
Why?
|
Risk Reduction Behavior | 1 | 2019 | 1125 | 0.030 |
Why?
|
Retinal Diseases | 1 | 2018 | 684 | 0.030 |
Why?
|
Reminder Systems | 1 | 2015 | 371 | 0.030 |
Why?
|
Sex Distribution | 1 | 2016 | 2297 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2017 | 77460 | 0.020 |
Why?
|
Age Distribution | 1 | 2016 | 2902 | 0.020 |
Why?
|
Self Report | 1 | 2020 | 3553 | 0.020 |
Why?
|
Weight Loss | 1 | 2020 | 2625 | 0.020 |
Why?
|
Life Style | 1 | 2020 | 3835 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2019 | 57776 | 0.020 |
Why?
|
Anxiety Disorders | 1 | 2020 | 2690 | 0.020 |
Why?
|
Young Adult | 3 | 2019 | 56429 | 0.020 |
Why?
|
Overweight | 1 | 2019 | 2371 | 0.020 |
Why?
|
Body Weight | 1 | 2018 | 4671 | 0.020 |
Why?
|
Osteoarthritis | 1 | 2015 | 1036 | 0.020 |
Why?
|
Insulin Resistance | 1 | 2020 | 3864 | 0.020 |
Why?
|
Mental Health | 1 | 2020 | 3010 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10400 | 0.020 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2019 | 2200 | 0.020 |
Why?
|
Anxiety | 1 | 2020 | 4293 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2015 | 2278 | 0.020 |
Why?
|
Logistic Models | 1 | 2018 | 13409 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18373 | 0.010 |
Why?
|
Diet | 1 | 2019 | 7937 | 0.010 |
Why?
|
Research Design | 1 | 2017 | 5984 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2018 | 21748 | 0.010 |
Why?
|
Smoking | 1 | 2016 | 8987 | 0.010 |
Why?
|
Pregnancy | 1 | 2016 | 29144 | 0.010 |
Why?
|
Animals | 1 | 2023 | 168768 | 0.010 |
Why?
|
Adolescent | 1 | 2018 | 85779 | 0.010 |
Why?
|